• Dinaciclib (SCH727965) for Reliable Cell Assays

  2026-09-20

  This scenario-driven guide shows how Dinaciclib (SCH727965), SKU A8412, can support reproducible cell-cycle, viability, and apoptosis experiments. It connects practical assay controls with the compound’s documented CDK1, CDK2, CDK5, and CDK9 activity while clarifying interpretation limits in tissue-boundary studies.

• Carbapenemase Transmission in CREC Across Guangdong

  2026-09-19

  This 2025 BMC Microbiology study combined gene localization, plasmid conjugation, antimicrobial susceptibility testing, and ERIC-PCR to characterize carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong. Its central finding is that blaNDM-1 was widely distributed across plasmids and chromosomes and transferred efficiently, highlighting the need to connect resistance genes with mobile elements, bacterial relatedness, and hospital epidemiology.

• From Netrin-1 Biology to Better RNA Readouts

  2026-09-18

  The study of adipose-derived Netrin-1 illustrates how mechanistic hypotheses can be weakened by RNA-quality and reverse-transcription constraints. This thought-leadership guide connects adipose remodeling biology with assay strategy, showing where HyperScript™ Reverse Transcriptase can support more reliable translational readouts without overstating what an enzyme can prove.

• Imidazoline Antagonists and β-Cell K+ Channels

  2026-09-18

  Jonas, Plant, and Henquin showed that several imidazoline α2-adrenoceptor antagonists enhance insulin release primarily by inhibiting ATP-sensitive K+ channels in pancreatic β-cells. By combining 86Rb efflux, whole-cell patch clamp, and pharmacological rescue experiments, the study separated direct ion-channel effects from receptor antagonism and established a useful framework for interpreting drug-induced insulin secretion.

• Sulfachloropyridazine: From DHPS to Microbiome Insight

  2026-09-17

  Sulfachloropyridazine is more than a conventional antifolate tool. By connecting DHPS inhibition with susceptibility testing, infection biology, microbiome profiling, and metabolomics, translational researchers can use this sulfonamide antibacterial agent to distinguish direct antimicrobial activity from broader ecosystem effects.

• Mechanical Stress-Induced Autophagy and Cytoskeletal Control

  2026-09-17

  The reference study shows that autophagy triggered by compressive force depends primarily on cytoskeletal microfilaments, while microtubules provide an auxiliary contribution. By combining cytoskeletal polymerization modulators with fluorescence imaging and western blotting, the work connects cellular mechanical properties to autophagosome responses and provides a framework for studying mechanotransduction.

• Atrial Natriuretic Peptide: Workflow & Applications

  2026-09-16

  Build reproducible cardiovascular assays around a research-grade ANP peptide hormone, from formulation and dose-response design to vascular, renal, and adipose endpoints. The workflow also shows how to use the reference study as a complementary neuroinflammation model without overstating evidence for ANP itself.

• Tigecycline Workflows for MDR Bacterial Research

  2026-09-16

  Build reproducible susceptibility, time-kill, and resistance-surveillance workflows with Tigecycline, a glycylcycline antibiotic suited to challenging bacterial panels. This guide connects phenotypic testing with plasmid-transmission analysis while highlighting formulation, endpoint, and interpretation controls.

• Acetylspiramycin in Resistance Assays

  2026-09-15

  Acetylspiramycin (Spiramycin B) gives researchers a 16-membered macrolide comparator for ribosome-focused susceptibility testing, especially when erythromycin and azithromycin resistance complicates interpretation. This guide converts recent Mycoplasma pneumoniae findings into practical broth microdilution, resistance-monitoring, and host–pathogen workflows.

• Sulforaphane, ROS, and NLRP3 in Experimental Colitis

  2026-09-15

  A 2024 Biomedicine & Pharmacotherapy study investigated how Sulforaphane reduces dextran sodium sulfate-induced colitis by lowering reactive oxygen species and suppressing NLRP3 inflammasome signaling. By combining mouse experiments with RAW264.7 macrophage studies, the work provides a mechanistic framework for examining redox-sensitive inflammation in ulcerative colitis research.

• Mitochondrial CAT-Tailing Drives Glioblastoma Growth

  2026-09-14

  The reference study identifies mitochondrial stress-induced carboxyl-terminal alanine and threonine tailing as a functional ribosome-associated quality-control response that supports glioblastoma survival. By linking CAT-tailed ATP5α to membrane-potential maintenance, permeability-transition control, apoptosis resistance, and migration, the work suggests a mechanistic connection between translational stress and tumor progression.

• 4-MUG Workflows for Lysosomal Enzyme Assays

  2026-09-14

  4-Methylumbelliferyl-β-D-Glucopyranoside converts β-glucosidase and β-glucocerebrosidase activity into a sensitive fluorescent readout for lysosomal studies, Gaucher disease models, and screening. This practical guide explains assay setup, mRNA-therapy workflows, optimization choices, and troubleshooting for reproducible 4-MUG measurements.

• Necrosulfonamide: Mapping Necroptosis to Translation

  2026-09-13

  Necrosulfonamide provides a pathway-positioned way to test whether MLKL membrane execution links upstream stress biology to translational injury. This article interprets recent cardiac microvascular ischemia–reperfusion findings and offers a practical framework for using NSA in mechanistic, cancer, and exploratory neurodegenerative disease models.

• COX-2, Ischemia, and Muscle Revascularization

  2026-09-12

  This study shows that COX-2 has a time-dependent role after Bothrops asper venom injury: it protects muscle microvessels during acute ischemia, yet its early inhibition later enhances proangiogenic and matrix-remodeling signals. The findings refine how selective COX-2 inhibition should be interpreted in muscle injury and revascularization models.

• Leptin (116-130), amide, mouse Workflows

  2026-09-11

  Use this defined leptin fragment to build controlled assays for energy balance, obesity, diabetes, and immunometabolic signaling. Practical preparation guidance, comparative assay design, and a cautious SIRT6–AMPK–NLRP3 extension help distinguish direct peptide effects from context-dependent leptin resistance.

8743 records 5/583 page Previous Next 12345 下5页 Last page